Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595666 | SCV000703924 | uncertain significance | not provided | 2016-12-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001325065 | SCV001516040 | uncertain significance | Niemann-Pick disease, type C1 | 2022-07-21 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 190 of the NPC1 protein (p.Ile190Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NPC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 498758). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001325065 | SCV002095224 | uncertain significance | Niemann-Pick disease, type C1 | 2020-06-02 | no assertion criteria provided | clinical testing |